* Apyx Medical Corp APYX.OQ reported a quarterly adjusted
loss
of 6 cents per share for the quarter ended in December. The
mean expectation of four analysts for the quarter was for a loss
of 11 cents per share.
* Revenue rose 46.8% to $16.82 million from a year ago;
analysts
expected $14.63 million.
* Apyx Medical Corp's reported EPS for the quarter was a
loss of 6
cents.
* The mean earnings estimate of analysts had risen by
about 12% in
the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Apyx Medical Corp shares had fallen by 45.9% this quarter.
* The company reported a quarterly loss of $2 million.
* Wall Street's median 12-month price target for Apyx
Medical Corp
is $20.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated March 17 at 01:31 p.m. All
figures in US dollars unless otherwise stated